CTXR

Citius Pharmaceuticals News

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
Level 1 Starter
Monthly Subscription
for only
$15.87
VAT not included
Company Name Stock Ticker Symbol Market Type
Citius Pharmaceuticals Inc CTXR NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
-0.02 -1.54% 1.28 1.24 1.34 1.30 1.30 11:16:58
more quote information »

Recent News

Date Time Source Heading
6/29/202009:07PRNUSCitius CEO Myron Holubiak to Appear on TD Ameritrade..
6/29/202008:35GLOBELife Sciences Companies Investor Presentations Now Available..
6/26/202009:16EDGARCurrent Report Filing (8-k)
6/26/202009:00PRNUSCitius Receives FDA Response on Pre-Investigational New Drug..
6/23/202008:49GLOBEVirtual Conference for Life Sciences Companies Broadcast..
6/22/202013:17PRNUSCitius Pharmaceuticals to Deliver Virtual Presentation at..
6/15/202006:01EDGARNotice of Effectiveness (effect)
6/12/202017:16EDGARProspectus Filed Pursuant to Rule 424(b)(3) (424b3)
6/05/202016:32EDGARSecurities Registration Statement (s-1)
6/02/202016:33EDGARCurrent Report Filing (8-k)
6/02/202009:30PRNUSCitius Receives Positive FDA Feedback on Its Submitted Plan..
5/26/202016:16EDGARCurrent Report Filing (8-k)
5/26/202008:15PRNUSCitius Announces Expanded Access Program for Investigational..
5/19/202011:45EDGARSmall Company Offering and Sale of Securities Without..
5/18/202016:11EDGARCurrent Report Filing (8-k)
5/18/202014:30PRNUSCitius Announces Closing of $7.5 Million Registered Direct..
5/15/202016:09EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
5/14/202016:28EDGARQuarterly Report (10-q)
5/14/202009:00PRNUSCitius Announces $7.5 Million Registered Direct Offering..
5/13/202008:15PRNUSCitius Announces Data on NoveCite Mesenchymal Stem Cells..
5/12/202010:52EDGARCurrent Report Filing (8-k)
5/12/202008:00PRNUSCitius Pharmaceuticals Issues May 2020 Shareholder Letter
4/29/202016:10EDGARCurrent Report Filing (8-k)
4/28/202008:31EDGARCurrent Report Filing (8-k)
4/27/202009:30PRNUSCitius Announces Pre-IND Submission to FDA Under the..
4/27/202006:01EDGARNotice of Effectiveness (effect)
4/24/202017:04EDGARProspectus Filed Pursuant to Rule 424(b)(3) (424b3)
4/10/202016:32EDGARSecurities Registration Statement (s-1)
4/07/202016:16EDGARCurrent Report Filing (8-k)
4/01/202008:38EDGARCurrent Report Filing (8-k)
4/01/202008:07PRNUSCitius Signs Exclusive Option with Novellus to License Novel..
3/26/202009:06PRNUSCitius Pharmaceuticals Announces Publication in..
3/18/202009:46PRNUSCitius Pharmaceuticals to Deliver Virtual Presentation at..
2/26/202008:00PRNUSCitius Pharmaceuticals to Present at the 2020 LD Micro..
2/25/202008:40EDGARCurrent Report Filing (8-k)
2/25/202008:00PRNUSCitius Pharmaceuticals Cites Independent Estimates of Total..
2/19/202016:20EDGARCurrent Report Filing (8-k)
2/18/202017:17EDGARProspectus Filed Pursuant to Rule 424(b)(3) (424b3)
2/18/202017:15EDGARProspectus Filed Pursuant to Rule 424(b)(3) (424b3)
2/14/202015:28EDGARAmended Statement of Ownership (sc 13g/a)
2/13/202016:18EDGARQuarterly Report (10-q)
2/10/202016:06EDGARCurrent Report Filing (8-k)
2/10/202008:28PRNUSCitius Pharmaceuticals to Present at Noble Capital Markets'..
2/06/202014:59EDGARAmended Statement of Ownership (sc 13g/a)
2/04/202009:28EDGARCurrent Report Filing (8-k)
2/04/202008:00PRNUSCitius Achieves 50% Patient Enrollment in Phase 3 Mino-LokĀ®..
2/03/202008:39EDGARCurrent Report Filing (8-k)
2/03/202008:00PRNUSCitius Pharmaceuticals Regains Compliance with Nasdaq..
1/22/202016:54EDGARCurrent Report Filing (8-k)
12/20/201916:34EDGARProxy Statement (definitive) (def 14a)
See more news about this stock »
Your Recent History
NASDAQ
CTXR
Citius Pha..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200709 15:33:01